CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 85 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,113,000 | +165.6% | 218,143 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $419,000 | -74.6% | 218,143 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,650,000 | +171.4% | 436,286 | +123.9% | 0.00% | 0.0% |
| Q2 2018 | $608,000 | +54.3% | 194,822 | +18.0% | 0.00% | 0.0% |
| Q1 2018 | $394,000 | -20.4% | 165,060 | +30.3% | 0.00% | 0.0% |
| Q4 2017 | $495,000 | +55.2% | 126,696 | 0.0% | 0.00% | – |
| Q3 2017 | $319,000 | -8.9% | 126,696 | 0.0% | 0.00% | – |
| Q2 2017 | $350,000 | +171.3% | 126,696 | +14.6% | 0.00% | – |
| Q1 2016 | $129,000 | -52.4% | 110,543 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $271,000 | -18.4% | 110,543 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $332,000 | -27.4% | 110,543 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $457,000 | – | 110,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |